UK markets closed

Thermo Fisher Scientific Inc. (TMO.BA)

Buenos Aires - Buenos Aires Delayed price. Currency in ARS
Add to watchlist
29,233.50+381.50 (+1.32%)
At close: 04:59PM ART
Currency in ARS

Valuation measures4

Market cap (intra-day) 191.88T
Enterprise value 216.78T
Trailing P/E 2.14
Forward P/E 1.54
PEG ratio (5-yr expected) 0.13
Price/sales (ttm)0.30
Price/book (mrq)0.28
Enterprise value/revenue 5.10k
Enterprise value/EBITDA 19.11k

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 3157.86%
S&P500 52-week change 322.38%
52-week high 333,071.50
52-week low 30.00
50-day moving average 327,957.72
200-day moving average 323,189.17

Share statistics

Avg vol (3-month) 388
Avg vol (10-day) 337
Shares outstanding 5381.72M
Implied shares outstanding 66.56B
Float 8380.79M
% held by insiders 10.00%
% held by institutions 10.06%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 461.39
Forward annual dividend yield 40.21%
Trailing annual dividend rate 31.44
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.42%
Dividend date 3N/A
Ex-dividend date 414 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Mar 2024

Profitability

Profit margin 14.20%
Operating margin (ttm)16.67%

Management effectiveness

Return on assets (ttm)4.82%
Return on equity (ttm)13.62%

Income statement

Revenue (ttm)42.49B
Revenue per share (ttm)2.32
Quarterly revenue growth (yoy)-3.40%
Gross profit (ttm)N/A
EBITDA 10.78B
Net income avi to common (ttm)6.03B
Diluted EPS (ttm)13,690.05
Quarterly earnings growth (yoy)3.00%

Balance sheet

Total cash (mrq)7.25B
Total cash per share (mrq)18.99
Total debt (mrq)35.66B
Total debt/equity (mrq)78.17%
Current ratio (mrq)1.70
Book value per share (mrq)119.24

Cash flow statement

Operating cash flow (ttm)8.93B
Levered free cash flow (ttm)6.07B